We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00283530
Recruitment Status : Terminated (The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No further subjects will be enrolled. Terminated with IRB.)
First Posted : January 30, 2006
Last Update Posted : January 20, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.

Condition or disease Intervention/treatment
Cancer Procedure: Tumor biopsy

Detailed Description:
To identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.

Study Design

Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Identification of Tumor Phenotypes and Correlation to Clinical Outcomes in Patients Diagnosed With Cancer
Study Start Date : May 2003
Study Completion Date : July 2009
Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cancer subjects who have or will have tissue and or blood collected.
Criteria

Inclusion Criteria:

  • Diagnosis of cancer receiving chemotherapy
  • Have had or will have tissue and/or blood samples collected
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00283530


Locations
United States, Kentucky
Kentuckiana Cancer Institute
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
Kentuckiana Cancer Institute
Investigators
Study Director: Shawn D. Glisson, MD Kentuckiana Cancer Institute
More Information

ClinicalTrials.gov Identifier: NCT00283530     History of Changes
Other Study ID Numbers: 1050203
CPTAIV-0020-385
First Posted: January 30, 2006    Key Record Dates
Last Update Posted: January 20, 2010
Last Verified: January 2010

Keywords provided by Kentuckiana Cancer Institute:
Cancer
Cancer receiving chemotherapy
Tumor biopsy